This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Barbara Anne Sullivan: Innovator in Medical Treatment
Introduction
Barbara Anne Sullivan is a prominent inventor based in Newbury Park, California. She has made significant contributions to the field of medical treatment, particularly in the area of gastrointestinal health. Her innovative work has led to the development of a unique method for treating conditions associated with cell trafficking in the gastrointestinal tract.
Latest Patents
Barbara holds a patent for the "Administration of alpha4beta7 hetero-dimer-specific antibody." This patent describes a method of treating subjects afflicted with conditions related to inappropriate trafficking of cells expressing alpha4beta7 to the gastrointestinal tract. The method involves administering an alpha4beta7 heterodimer specific antibody in an amount and at intervals sufficient to ameliorate the condition. This innovative approach has the potential to improve the quality of life for many patients.
Career Highlights
Barbara is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. Her work at Amgen has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to medical science.
Collaborations
Some of Barbara's notable coworkers include Dominique Christian Borie and Hailing Hsu. Their collaborative efforts have played a crucial role in advancing research and development in their respective areas of expertise.
Conclusion
Barbara Anne Sullivan is a remarkable inventor whose work has the potential to transform medical treatment for gastrointestinal conditions. Her innovative patent and contributions at Amgen Inc. highlight her dedication to improving patient outcomes.